Literature DB >> 11087067

Cultivation of recombinant Escherichia coli to achieve high cell density with a high level of penicillin G acylase activity.

Y C Liu1, L C Liao, W T Wu.   

Abstract

A mutant strain of E. coli EP1 harbouring pGL-5 was employed to develop a process for producing penicillin G acylase (PGA). In comparison with different carbon sources in the medium, it was found that the specific levels of PGA activity obtained in the glucose medium were the lowest. which was likely due to catabolic repression. Phenylacetic acid (PAA) was previously reported to be an regulatory inducer for PGA production, whereas in this study, the addition of PAA repressed both cell growth and enzyme expression. In a fed-batch culture, the increase of specific PGA activity followed the pattern of the cell concentration during the early to middle cell growth phase. With application of pure oxygen aeration and an appropriate medium design, the cell concentration reached 162 (g wet weight/l), which was 2.4 times higher compared to that of the original operation, and a specific PGA activity of 37 (IU/g wet weight) was achieved after 12 h of cultivation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11087067

Source DB:  PubMed          Journal:  Proc Natl Sci Counc Repub China B        ISSN: 0255-6596


  3 in total

1.  Application of the BPEC pathway for large-scale biotechnological production of poly(3-mercaptopropionate) by recombinant Escherichia coli, including a novel in situ isolation method.

Authors:  Nehal Thakor; Tina Lütke-Eversloh; Alexander Steinbüchel
Journal:  Appl Environ Microbiol       Date:  2005-02       Impact factor: 4.792

2.  Improvement of posttranslational bottlenecks in the production of penicillin amidase in recombinant Escherichia coli strains.

Authors:  Z Ignatova; A Mahsunah; M Georgieva; V Kasche
Journal:  Appl Environ Microbiol       Date:  2003-02       Impact factor: 4.792

Review 3.  Exploitation of E. coli for the production of penicillin G amidase: a tool for the synthesis of semisynthetic β-lactam antibiotics.

Authors:  Krishika Sambyal; Rahul Vikram Singh
Journal:  J Genet Eng Biotechnol       Date:  2021-10-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.